246 related articles for article (PubMed ID: 19360350)
61.
Bhattacharya A; Mukherjee S; Khan P; Banerjee S; Dutta A; Banerjee N; Sengupta D; Basak U; Chakraborty S; Dutta A; Chattopadhyay S; Jana K; Sarkar DK; Chatterjee S; Das T
Sci Signal; 2020 Oct; 13(654):. PubMed ID: 33082288
[TBL] [Abstract][Full Text] [Related]
62. Expressional changes in stemness markers post electrochemotherapy in pancreatic cancer cells.
Ali MS; Gill KS; Saglio G; Cilloni D; Soden DM; Forde PF
Bioelectrochemistry; 2018 Aug; 122():84-92. PubMed ID: 29574322
[TBL] [Abstract][Full Text] [Related]
63. Expression and role of Oct3/4, Nanog and Sox2 in regeneration of rat tracheal epithelium.
Song N; Jia XS; Jia LL; Ma XB; Li F; Wang EH; Li X
Cell Prolif; 2010 Feb; 43(1):49-55. PubMed ID: 19845688
[TBL] [Abstract][Full Text] [Related]
64. Genes involved in regulation of stem cell properties: studies on their expression in a small cohort of neuroblastoma patients.
Melone MA; Giuliano M; Squillaro T; Alessio N; Casale F; Mattioli E; Cipollaro M; Giordano A; Galderisi U
Cancer Biol Ther; 2009 Jul; 8(13):1300-6. PubMed ID: 19458492
[TBL] [Abstract][Full Text] [Related]
65. FOXO4 expression is related to stem cell-like properties and resistance to treatment in diffuse large B-cell lymphoma.
Ryu KJ; Park C; Hong M; Ko YH; Kim WS; Kim SJ
Oncotarget; 2017 Jan; 8(2):2466-2476. PubMed ID: 27911272
[TBL] [Abstract][Full Text] [Related]
66. Regulation of NANOG in cancer cells.
Gong S; Li Q; Jeter CR; Fan Q; Tang DG; Liu B
Mol Carcinog; 2015 Sep; 54(9):679-87. PubMed ID: 26013997
[TBL] [Abstract][Full Text] [Related]
67. Role of stress-activated OCT4A in the cell fate decisions of embryonal carcinoma cells treated with etoposide.
Huna A; Salmina K; Erenpreisa J; Vazquez-Martin A; Krigerts J; Inashkina I; Gerashchenko BI; Townsend PA; Cragg MS; Jackson TR
Cell Cycle; 2015; 14(18):2969-84. PubMed ID: 26102294
[TBL] [Abstract][Full Text] [Related]
68. Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile.
Hägerstrand D; He X; Bradic Lindh M; Hoefs S; Hesselager G; Ostman A; Nistér M
Neuro Oncol; 2011 Nov; 13(11):1178-91. PubMed ID: 21940738
[TBL] [Abstract][Full Text] [Related]
69. Calpain-6 controls the fate of sarcoma stem cells by promoting autophagy and preventing senescence.
Andrique C; Morardet L; Linares LK; Cissé MY; Merle C; Chibon F; Provot S; Haÿ E; Ea HK; Cohen-Solal M; Modrowski D
JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185659
[TBL] [Abstract][Full Text] [Related]
70. Stem cell transcription factor NANOG in cancers--is eternal youth a curse?
Wong OG; Cheung AN
Expert Opin Ther Targets; 2016; 20(4):407-17. PubMed ID: 26634876
[TBL] [Abstract][Full Text] [Related]
71. The inhibitory effect of 5,7-DMF on pancreatic sphere-forming cell function mediated by FoxM1 gene expression.
Zeng D; Ma J; Li R; Yang J; Yin X
J Cell Biochem; 2018 Feb; 119(2):1855-1865. PubMed ID: 28802012
[TBL] [Abstract][Full Text] [Related]
72. High Frequency of Tumor Propagating Cells in Fusion-Positive Rhabdomyosarcoma.
Generali M; Satheesha S; Bode PK; Wanner D; Schäfer BW; Casanova EA
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573355
[TBL] [Abstract][Full Text] [Related]
73. Aberrant Notch signaling in glioblastoma stem cells contributes to tumor recurrence and invasion.
Yu JB; Jiang H; Zhan RY
Mol Med Rep; 2016 Aug; 14(2):1263-8. PubMed ID: 27315154
[TBL] [Abstract][Full Text] [Related]
74. PlGF Knockdown Decreases Tumorigenicity and Stemness Properties of Spheroid Body Cells Derived from Gastric Cancer Cells.
Mahmoodi F; Akrami H
J Cell Biochem; 2017 Apr; 118(4):851-859. PubMed ID: 27735991
[TBL] [Abstract][Full Text] [Related]
75. Engineered Breast Cancer Cell Spheroids Reproduce Biologic Properties of Solid Tumors.
Ham SL; Joshi R; Luker GD; Tavana H
Adv Healthc Mater; 2016 Nov; 5(21):2788-2798. PubMed ID: 27603912
[TBL] [Abstract][Full Text] [Related]
76. Cancer stem cells in sarcomas: Getting to the stemness core.
Skoda J; Veselska R
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2134-2139. PubMed ID: 30003939
[TBL] [Abstract][Full Text] [Related]
77. BMP-2 inhibits the tumorigenicity of cancer stem cells in human osteosarcoma OS99-1 cell line.
Wang L; Park P; Zhang H; La Marca F; Claeson A; Valdivia J; Lin CY
Cancer Biol Ther; 2011 Mar; 11(5):457-63. PubMed ID: 21178508
[TBL] [Abstract][Full Text] [Related]
78. 8-Bromo-7-methoxychrysin-blocked STAT3/Twist axis inhibits the stemness of cancer stem cell-like cell originated from SMMC-7721 cells.
Luo Y; Cui Y; Cao X; Li X; Chen A; Zhang J; Chen X; Cao J
Acta Biochim Biophys Sin (Shanghai); 2017 May; 49(5):458-464. PubMed ID: 28369327
[TBL] [Abstract][Full Text] [Related]
79. Micrometastatic Drug Screening Platform Shows Heterogeneous Response to MAP Chemotherapy in Osteosarcoma Cell Lines.
Collier CD; Wirtz EC; Knafler GJ; Morris WZ; Getty PJ; Greenfield EM
Clin Orthop Relat Res; 2018 Jul; 476(7):1400-1411. PubMed ID: 29481344
[TBL] [Abstract][Full Text] [Related]
80. The Tissue-Reconstructing Ability of Colon CSCs Is Enhanced by FK506 and Suppressed by GSK3 Inhibition.
Ishida R; Koyanagi-Aoi M; Oshima N; Kakeji Y; Aoi T
Mol Cancer Res; 2017 Oct; 15(10):1455-1466. PubMed ID: 28710230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
